Sana Biotechnology reports 14-month type 1 diabetes trial results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Sana Biotechnology reports 14-month type 1 diabetes trial results
(NASDAQ: SANA) Delayed: 4.01 +0.45 (12.64%)
Previous Close $3.56    52 Week High $ 
Open $3.61    52 Week Low $ 
Day High $4.02    P/E N/A 
Day Low $3.61    EPS $ 
Volume 5,315,393